Metraipolis › archive › dc_eb3854814d74

Targeted therapy in thyroid cancer: molecular alterations and clinical management — Europe PMC PMID:42325622

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42325622
DOI
10.3389/fendo.2026.1810813
License (as archived)
solo-consultazione
Archived
2026-10-31T18:39:19.946Z
SHA-256 of the archived text
ddd483aa84a1bec14d8f86d8cb2e0b9a5c4042a90d398284da43c304c6a08cb6
Stable URL of this page
https://metraipolis.com/documento/dc_eb3854814d74

How to cite

Targeted therapy in thyroid cancer: molecular alterations and clinical management — Europe PMC PMID:42325622 — Europe PMC (en), https://europepmc.org/article/MED/42325622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb3854814d74 (Metraipolis archive dc_eb3854814d74, sha256 ddd483aa84a1bec14d8f86d8cb2e0b9a5c4042a90d398284da43c304c6a08cb6)
BibTeX
@misc{dceb3854814d74,
  title = {Targeted therapy in thyroid cancer: molecular alterations and clinical management — Europe PMC PMID:42325622},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42325622},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb3854814d74; sha256 ddd483aa84a1bec14d8f86d8cb2e0b9a5c4042a90d398284da43c304c6a08cb6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42325622. Agents can read the archived copy with the MCP tool read_document.